{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:33:49Z","timestamp":1793090029479,"version":"4.5.0"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Russian Science Foundation","award":["\u2116 26-15-00054"],"award-info":[{"award-number":["\u2116 26-15-00054"]}],"id":[{"id":"https:\/\/ror.org\/03y2gwe85","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Trace Elem Res"],"DOI":"10.1007\/s12011-026-05288-y","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T01:35:14Z","timestamp":1786584914000},"page":"8637-8660","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Size-Dependent Differences in the Effects of Low-Dose Selenium Nanoparticles on Chronic Thioacetamide Toxicosis Accompanying HCC Progression in Mice"],"prefix":"10.1007","volume":"204","author":[{"given":"Anastasia A.","family":"Abramova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir V.","family":"Rogachev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilya V.","family":"Baimler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey V.","family":"Gudkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena G.","family":"Varlamova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"5288_CR1","doi-asserted-by":"publisher","unstructured":"Varlamova EG (2026) Selenium-containing compounds in breast cancer therapy. Biol Trace Elem Res 13. https:\/\/doi.org\/10.1007\/s12011-026-05026-4","DOI":"10.1007\/s12011-026-05026-4"},{"key":"5288_CR2","doi-asserted-by":"publisher","first-page":"127620","DOI":"10.1016\/j.jtemb.2025.127620","volume":"88","author":"EG Varlamova","year":"2025","unstructured":"Varlamova EG (2025) Selenium-containing compounds, selenium nanoparticles and selenoproteins in the prevention and treatment of lung cancer. J Trace Elem Med Biol 88:127620. https:\/\/doi.org\/10.1016\/j.jtemb.2025.127620","journal-title":"J Trace Elem Med Biol"},{"issue":"7","key":"5288_CR3","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.3390\/ijms24076469","volume":"24","author":"VV Rogachev","year":"2023","unstructured":"Rogachev VV, Goltyaev MV, Varlamova EG, Turovsky EA (2023) Molecular Mechanisms of the Cytotoxic Effect of Recombinant Selenoprotein SELENOM on Human Glioblastoma Cells. Int J Mol Sci 24(7):6469. https:\/\/doi.org\/10.3390\/ijms24076469","journal-title":"Int J Mol Sci"},{"key":"5288_CR4","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jtemb.2018.04.005","volume":"48","author":"EG Varlamova","year":"2018","unstructured":"Varlamova EG (2018) Participation of selenoproteins localized in the ER in the processes occurring in this organelle and in the regulation of carcinogenesis-associated processes. J Trace Elem Med Biol 48:172\u2013180. https:\/\/doi.org\/10.1016\/j.jtemb.2018.04.005","journal-title":"J Trace Elem Med Biol"},{"key":"5288_CR5","doi-asserted-by":"publisher","unstructured":"Varlamova EG, Novoselov SV, Novoselov VI, Fesenko EE (2011) New mammalian selenium-containing protein V: the search for protein partners. Dokl Biochem Biophys 441:255\u2013257. https:\/\/doi.org\/10.1134\/S1607672911060056","DOI":"10.1134\/S1607672911060056"},{"issue":"1","key":"5288_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1134\/S160767292001007X","volume":"490","author":"MV Goltyaev","year":"2020","unstructured":"Goltyaev MV, Varlamova EG, Novoselov SV, Fesenko EE (2020) Activation of Signal Pathways of Apoptosis under Conditions of Prolonged ER-Stress Caused by Exposure of Mouse Testicular Teratoma Cells to Selenium-Containing Compounds. Dokl Biochem Biophys 490(1):9\u201311. https:\/\/doi.org\/10.1134\/S160767292001007X","journal-title":"Dokl Biochem Biophys"},{"issue":"1","key":"5288_CR7","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1134\/S1607672916030121","volume":"468","author":"EG Varlamova","year":"2016","unstructured":"Varlamova EG, Goltyaev MV, Fesenko EE (2016) Expression of human selenoprotein genes selh, selk, selm, sels, selv, and gpx-6 in various tumor cell lines. Dokl Biochem Biophys 468(1):203\u2013205. https:\/\/doi.org\/10.1134\/S1607672916030121","journal-title":"Dokl Biochem Biophys"},{"issue":"8","key":"5288_CR8","doi-asserted-by":"publisher","first-page":"743","DOI":"10.3390\/biology10080743","volume":"10","author":"EA Turovsky","year":"2021","unstructured":"Turovsky EA, Varlamova EG (2021) Mechanism of Ca2+-Dependent Pro-Apoptotic Action of Selenium Nanoparticles, Mediated by Activation of Cx43 Hemichannels. Biology (Basel) 10(8):743. https:\/\/doi.org\/10.3390\/biology10080743","journal-title":"Biology (Basel)"},{"issue":"13","key":"5288_CR9","doi-asserted-by":"publisher","first-page":"10547","DOI":"10.3390\/ijms241310547","volume":"24","author":"MV Goltyaev","year":"2023","unstructured":"Goltyaev MV, Varlamova EG (2023) The Role of Selenium Nanoparticles in the Treatment of Liver Pathologies of Various Natures. Int J Mol Sci 24(13):10547. https:\/\/doi.org\/10.3390\/ijms241310547","journal-title":"Int J Mol Sci"},{"issue":"9","key":"5288_CR10","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.2217\/nnm-2017-0024","volume":"12","author":"F Maiyo","year":"2017","unstructured":"Maiyo F, Singh M (2017) Selenium nanoparticles: potential in cancer gene and drug delivery. Nanomed (Lond) 12(9):1075\u20131089. https:\/\/doi.org\/10.2217\/nnm-2017-0024","journal-title":"Nanomed (Lond)"},{"key":"5288_CR11","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.biopha.2018.12.146","volume":"111","author":"A Khurana","year":"2019","unstructured":"Khurana A, Tekula S, Saifi MA, Venkatesh P, Godugu C (2019) Therapeutic applications of selenium nanoparticles. Biomed Pharmacother 111:802\u2013812. https:\/\/doi.org\/10.1016\/j.biopha.2018.12.146","journal-title":"Biomed Pharmacother"},{"issue":"10","key":"5288_CR12","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.1166\/jbn.2014.1985","volume":"10","author":"S Chaudhary","year":"2014","unstructured":"Chaudhary S, Umar A, Mehta SK (2014) Surface functionalized selenium nanoparticles for biomedical applications. J Biomed Nanotechnol 10(10):3004\u20133042. https:\/\/doi.org\/10.1166\/jbn.2014.1985","journal-title":"J Biomed Nanotechnol"},{"issue":"6","key":"5288_CR13","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1007\/s00253-016-7300-7","volume":"100","author":"SA Wadhwani","year":"2016","unstructured":"Wadhwani SA, Shedbalkar UU, Singh R, Chopade BA (2016) Biogenic selenium nanoparticles: current status and future prospects. Appl Microbiol Biotechnol 100(6):2555\u20132566. https:\/\/doi.org\/10.1007\/s00253-016-7300-7","journal-title":"Appl Microbiol Biotechnol"},{"issue":"10","key":"5288_CR14","doi-asserted-by":"publisher","first-page":"e70013","DOI":"10.1111\/1751-7915.70013","volume":"17","author":"E Lashani","year":"2024","unstructured":"Lashani E, Moghimi H, Turner RJ, Amoozegar MA (2024) Characterization and biological activity of selenium nanoparticles biosynthesized by Yarrowia lipolytica. Microb Biotechnol 17(10):e70013. https:\/\/doi.org\/10.1111\/1751-7915.70013","journal-title":"Microb Biotechnol"},{"key":"5288_CR15","doi-asserted-by":"publisher","first-page":"124448","DOI":"10.1016\/j.jchromb.2024.124448","volume":"1252","author":"C Chen","year":"2025","unstructured":"Chen C, Yang Z, Ma J, Xie W, Wang Z (2025) Recent research progress on the biological functions, synthesis and applications of selenium nanoparticles. J Chromatogr B Analyt Technol Biomed Life Sci 1252:124448. https:\/\/doi.org\/10.1016\/j.jchromb.2024.124448","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"12","key":"5288_CR16","doi-asserted-by":"publisher","first-page":"6641","DOI":"10.3390\/ijms23126641","volume":"23","author":"EG Varlamova","year":"2022","unstructured":"Varlamova EG, Goltyaev MV, Simakin AV, Gudkov SV, Turovsky EA (2022) Comparative Analysis of the Cytotoxic Effect of a Complex of Selenium Nanoparticles Doped with Sorafenib, Naked Selenium Nanoparticles, and Sorafenib on Human Hepatocyte Carcinoma HepG2 Cells. Int J Mol Sci 23(12):6641. https:\/\/doi.org\/10.3390\/ijms23126641","journal-title":"Int J Mol Sci"},{"issue":"9","key":"5288_CR17","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.3390\/biom15091336","volume":"15","author":"EA Turovsky","year":"2025","unstructured":"Turovsky EA, Gudkov SV, Varlamova EG (2025) Therapeutic Effect of Selenium Nanoparticles, Sorafenib, and Selenium-Sorafenib Nanocomplex in the Lungs and Kidneys of Mice with TAA-Induced HCC. Biomolecules 15(9):1336. https:\/\/doi.org\/10.3390\/biom15091336","journal-title":"Biomolecules"},{"key":"5288_CR18","doi-asserted-by":"publisher","first-page":"127800","DOI":"10.1016\/j.jtemb.2025.127800","volume":"93","author":"EG Varlamova","year":"2026","unstructured":"Varlamova EG, Gudkov SV, Rogachev VV, Turovsky EA (2026) Therapeutic effects of a new selenium-sorafenib nanocomplex in liver and tumor in a TAA-induced HCC model. J Trace Elem Med Biol 93:127800. https:\/\/doi.org\/10.1016\/j.jtemb.2025.127800","journal-title":"J Trace Elem Med Biol"},{"issue":"1","key":"5288_CR19","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s12011-025-04682-2","volume":"204","author":"EG Varlamova","year":"2026","unstructured":"Varlamova EG, Gudkov SV, Turovsky EA (2026) Opposite Effects of Small and Large Diameter Selenium Nanoparticles on the Redox-Status and Survival of Cortical Cells in Toxic Models In Vitro. Biol Trace Elem Res 204(1):300\u2013321. https:\/\/doi.org\/10.1007\/s12011-025-04682-2","journal-title":"Biol Trace Elem Res"},{"issue":"23","key":"5288_CR20","doi-asserted-by":"publisher","first-page":"12825","DOI":"10.3390\/ijms222312825","volume":"22","author":"EG Varlamova","year":"2021","unstructured":"Varlamova EG, Turovsky EA, Babenko VA, Plotnikov EY (2021) The Mechanisms Underlying the Protective Action of Selenium Nanoparticles against Ischemia\/Reoxygenation Are Mediated by the Activation of the Ca2\u2009+\u2009Signaling System of Astrocytes and Reactive Astrogliosis. Int J Mol Sci 22(23):12825. https:\/\/doi.org\/10.3390\/ijms222312825","journal-title":"Int J Mol Sci"},{"issue":"6","key":"5288_CR21","doi-asserted-by":"publisher","first-page":"e70210","DOI":"10.1002\/cnr2.70210","volume":"8","author":"S Anjum","year":"2025","unstructured":"Anjum S, Hashim M, Imran M, Babur S, Adnan S, Hano C, Ibrahim WN (2025) Selenium Nanoparticles in Cancer Therapy: Unveiling Cytotoxic Mechanisms and Therapeutic Potential. Cancer Rep (Hoboken) 8(6):e70210. https:\/\/doi.org\/10.1002\/cnr2.70210","journal-title":"Cancer Rep (Hoboken)"},{"issue":"4","key":"5288_CR22","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.coph.2007.05.005","volume":"7","author":"WW Huber","year":"2007","unstructured":"Huber WW, Parzefall W (2007) Thiols and the chemoprevention of cancer. Curr Opin Pharmacol 7(4):404\u2013409. https:\/\/doi.org\/10.1016\/j.coph.2007.05.005","journal-title":"Curr Opin Pharmacol"},{"issue":"9","key":"5288_CR23","doi-asserted-by":"publisher","first-page":"720","DOI":"10.2174\/1389557517666161104125022","volume":"19","author":"B Lipinski","year":"2019","unstructured":"Lipinski B (2019) Redox-Active Selenium in Health and Disease: A Conceptual Review. Mini Rev Med Chem 19(9):720\u2013726. https:\/\/doi.org\/10.2174\/1389557517666161104125022","journal-title":"Mini Rev Med Chem"},{"issue":"1","key":"5288_CR24","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1007\/s11033-024-09598-z","volume":"51","author":"JA Ansari","year":"2024","unstructured":"Ansari JA, Malik JA, Ahmed S, Manzoor M, Ahemad N, Anwar S (2024) Recent advances in the therapeutic applications of selenium nanoparticles. Mol Biol Rep 51(1):688. https:\/\/doi.org\/10.1007\/s11033-024-09598-z","journal-title":"Mol Biol Rep"},{"issue":"2","key":"5288_CR25","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1021\/acsbiomaterials.4c01130","volume":"11","author":"Y Lv","year":"2025","unstructured":"Lv Y, Chen Z, Wang S, Zou M (2025) Macrophage-Mediated Liquid Metal Nanoparticles for Enhanced Tumor Accumulation and Inhibition. ACS Biomater Sci Eng 11(2):903\u2013915. https:\/\/doi.org\/10.1021\/acsbiomaterials.4c01130","journal-title":"ACS Biomater Sci Eng"},{"issue":"6","key":"5288_CR26","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3390\/jpm11060571","volume":"11","author":"MA Subhan","year":"2021","unstructured":"Subhan MA, Yalamarty SSK, Filipczak N, Parveen F, Torchilin VP (2021) Recent Advances in Tumor Targeting via EPR Effect for Cancer Treatment. J Pers Med 11(6):571. https:\/\/doi.org\/10.3390\/jpm11060571","journal-title":"J Pers Med"},{"key":"5288_CR27","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.jconrel.2022.03.043","volume":"345","author":"M Ikeda-Imafuku","year":"2022","unstructured":"Ikeda-Imafuku M, Wang LL, Rodrigues D, Shaha S, Zhao Z, Mitragotri S (2022) Strategies to improve the EPR effect: A mechanistic perspective and clinical translation. J Control Release 345:512\u2013536. https:\/\/doi.org\/10.1016\/j.jconrel.2022.03.043","journal-title":"J Control Release"},{"issue":"3","key":"5288_CR28","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3390\/jpm13030389","volume":"13","author":"MA Subhan","year":"2023","unstructured":"Subhan MA, Parveen F, Filipczak N, Yalamarty SSK, Torchilin VP (2023) Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis. J Pers Med 13(3):389. https:\/\/doi.org\/10.3390\/jpm13030389","journal-title":"J Pers Med"},{"key":"5288_CR29","doi-asserted-by":"publisher","first-page":"103404","DOI":"10.1016\/j.redox.2024.103404","volume":"77","author":"C Glorieux","year":"2024","unstructured":"Glorieux C, Buc Calderon P (2024) Targeting catalase in cancer. Redox Biol 77:103404. https:\/\/doi.org\/10.1016\/j.redox.2024.103404","journal-title":"Redox Biol"},{"issue":"10","key":"5288_CR30","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1515\/hsz-2017-0131","volume":"398","author":"C Glorieux","year":"2017","unstructured":"Glorieux C, Calderon PB (2017) Catalase, a remarkable enzyme: targeting the oldest antioxidant enzyme to find a new cancer treatment approach. Biol Chem 398(10):1095\u20131108. https:\/\/doi.org\/10.1515\/hsz-2017-0131","journal-title":"Biol Chem"},{"issue":"3","key":"5288_CR31","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.tcb.2020.12.006","volume":"31","author":"Y Fujiki","year":"2021","unstructured":"Fujiki Y, Bassik MC (2021) A New Paradigm in Catalase Research. Trends Cell Biol 31(3):148\u2013151. https:\/\/doi.org\/10.1016\/j.tcb.2020.12.006","journal-title":"Trends Cell Biol"},{"issue":"1","key":"5288_CR32","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s40659-024-00577-z","volume":"57","author":"N Quilaqueo-Millaqueo","year":"2024","unstructured":"Quilaqueo-Millaqueo N, Brown-Brown DA, Vidal-Vidal JA, Niechi I (2024) NOX proteins and ROS generation: role in invadopodia formation and cancer cell invasion. Biol Res 57(1):98. https:\/\/doi.org\/10.1186\/s40659-024-00577-z","journal-title":"Biol Res"},{"issue":"1","key":"5288_CR33","doi-asserted-by":"publisher","first-page":"24612","DOI":"10.1038\/s41598-025-09690-9","volume":"15","author":"J Sun","year":"2025","unstructured":"Sun J, Gong Z, Zheng L, Ding Z, Wang L, Tang Y, Deng S, Dong Y, Tang H (2025) NOX4 serves as a pan-cancer prognostic biomarker and therapeutic target in tumorigenesis. Sci Rep 15(1):24612. https:\/\/doi.org\/10.1038\/s41598-025-09690-9","journal-title":"Sci Rep"},{"issue":"1","key":"5288_CR34","doi-asserted-by":"publisher","first-page":"18812","DOI":"10.1038\/s41598-025-03499-2","volume":"15","author":"Y Liu","year":"2025","unstructured":"Liu Y, Wu C, Wang Q, Zhao X, Jiang X (2025) NOX4 as an emerging prognostic and immunological biomarker across pan-cancer analyses. Sci Rep 15(1):18812. https:\/\/doi.org\/10.1038\/s41598-025-03499-2","journal-title":"Sci Rep"},{"issue":"2","key":"5288_CR35","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1080\/10715762.2026.2643692","volume":"60","author":"MR Islam","year":"2026","unstructured":"Islam MR, Alam R, Islam F, Nagar P, Rahman MA (2026) Mitochondrial antioxidant enzyme (SOD2) at the crossroads of redox signaling and cancer progression. Free Radic Res 60(2):183\u2013200. https:\/\/doi.org\/10.1080\/10715762.2026.2643692","journal-title":"Free Radic Res"},{"issue":"9","key":"5288_CR36","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.5937\/jomb0-59010","volume":"44","author":"D Aydemir","year":"2026","unstructured":"Aydemir D, Ulusu NN (2026) Multifaceted roles of superoxide dismutases (SODs) in cellular homeostasis and cancer progression: Redox regulation and therapeutic implications. J Med Biochem 44(9):1891\u20131901. https:\/\/doi.org\/10.5937\/jomb0-59010","journal-title":"J Med Biochem"},{"issue":"1","key":"5288_CR37","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s10549-025-07775-7","volume":"213","author":"YY Kim","year":"2025","unstructured":"Kim YY, Lee G, Jeon Y, Gong G, Kim K, Kim J, Jeong BK, Lee HJ (2025) SOD2 expression in patients with triple-negative breast cancer is associated with tumor-infiltrating lymphocytes and prognosis. Breast Cancer Res Treat 213(1):181\u2013192. https:\/\/doi.org\/10.1007\/s10549-025-07775-7","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"5288_CR38","doi-asserted-by":"publisher","first-page":"14491","DOI":"10.1038\/s41598-023-41752-8","volume":"13","author":"R Gr\u0119bowski","year":"2023","unstructured":"Gr\u0119bowski R, Saluk J, Bijak M, Szemraj J, Wigner-Jeziorska P (2023) The role of SOD2 and NOS2 genes in the molecular aspect of bladder cancer pathophysiology. Sci Rep 13(1):14491. https:\/\/doi.org\/10.1038\/s41598-023-41752-8","journal-title":"Sci Rep"},{"key":"5288_CR39","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.jare.2025.05.033","volume":"80","author":"J Mei","year":"2026","unstructured":"Mei J, Tian HX, Zhang XY, Chen YS, Wang LY, Zhang Z, Zhang YL, Rong DC, Zeng J, Dong M, Gao Y, Yin JY, Wu HJ, Wang PY, Zhang W (2026) Heme oxygenase 1 (HO-1) is a drug target for reversing cisplatin resistance in non-small cell lung cancer. J Adv Res 80:1121\u20131137. https:\/\/doi.org\/10.1016\/j.jare.2025.05.033","journal-title":"J Adv Res"},{"issue":"17","key":"5288_CR40","doi-asserted-by":"publisher","first-page":"9195","DOI":"10.3390\/ijms25179195","volume":"25","author":"RJ Salloom","year":"2024","unstructured":"Salloom RJ, Ahmad IM, Sahtout DZ, Baine MJ, Abdalla MY (2024) Heme Oxygenase-1 and Prostate Cancer: Function, Regulation, and Implication in Cancer Therapy. Int J Mol Sci 25(17):9195. https:\/\/doi.org\/10.3390\/ijms25179195","journal-title":"Int J Mol Sci"},{"issue":"10","key":"5288_CR41","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1167\/iovs.65.10.37","volume":"65","author":"C Hou","year":"2024","unstructured":"Hou C, Wan Q, Xiao L, Xiao Q, Zhang M, Yan N (2024) Inhibition of Heme Oxygenase 1 Suppresses Growth, Migration, and Invasion, and Regulates Tumor-Infiltrating CD8\u2009+\u2009T Cells and in Uveal Melanoma. Invest Ophthalmol Vis Sci 65(10):37. https:\/\/doi.org\/10.1167\/iovs.65.10.37","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"5288_CR42","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3390\/antiox15030312","volume":"15","author":"EG Varlamova","year":"2026","unstructured":"Varlamova EG, Gudkov SV, Turovsky EA (2026) The Role of Se-Containing Glutathione Peroxidases and Thioredoxin Reductases in Oncogenesis: Expression Paradoxes and Therapeutic Prospects. Antioxid (Basel) 15(3):312. https:\/\/doi.org\/10.3390\/antiox15030312","journal-title":"Antioxid (Basel)"},{"key":"5288_CR43","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.freeradbiomed.2022.06.232","volume":"188","author":"RS Esworthy","year":"2022","unstructured":"Esworthy RS, Doroshow JH, Chu FF (2022) The beginning of GPX2 and 30 years later. Free Radic Biol Med 188:419\u2013433. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2022.06.232","journal-title":"Free Radic Biol Med"},{"issue":"7","key":"5288_CR44","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1089\/ars.2019.7905","volume":"33","author":"R Brigelius-Floh\u00e9","year":"2020","unstructured":"Brigelius-Floh\u00e9 R, Floh\u00e9 L (2020) Regulatory Phenomena in the Glutathione Peroxidase Superfamily. Antioxid Redox Signal 33(7):498\u2013516. https:\/\/doi.org\/10.1089\/ars.2019.7905","journal-title":"Antioxid Redox Signal"},{"key":"5288_CR45","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ejphar.2007.10.012","volume":"579","author":"X Wang","year":"2008","unstructured":"Wang X, Zhang J, Xu T (2008) Thioredoxin reductase inactivation as a pivotal mechanism of ifosfamide in cancer therapy. Eur J Pharmacol 579:66\u201373. https:\/\/doi.org\/10.1016\/j.ejphar.2007.10.012","journal-title":"Eur J Pharmacol"},{"key":"5288_CR46","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s43066-024-00309-8","volume":"14","author":"KM Abdelwahab","year":"2024","unstructured":"Abdelwahab KM, Ibrahim WA, Saleh SAB, Elbarky AAA, Mohamed GA (2024) Evaluation of serum thioredoxin as a hepatocellular carcinoma diagnostic marker. Egypt Liver J 14:3. https:\/\/doi.org\/10.1186\/s43066-024-00309-8","journal-title":"Egypt Liver J"},{"issue":"18","key":"5288_CR47","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.3390\/molecules24183333","volume":"24","author":"N Al-Kandari","year":"2019","unstructured":"Al-Kandari N, Fadel F, Al-Saleh F, Khashab F, Al-Maghrebi M (2019) The Thioredoxin System is Regulated by the ASK-1\/JNK\/p38\/Survivin Pathway During Germ Cell Apoptosis. Molecules 24(18):3333. https:\/\/doi.org\/10.3390\/molecules24183333","journal-title":"Molecules"},{"key":"5288_CR48","doi-asserted-by":"publisher","first-page":"9414","DOI":"10.1128\/MCB.24.21.9414-9423.2004","volume":"24","author":"M Conrad","year":"2004","unstructured":"Conrad M, Jakupoglu C, Moreno SG, Lippl S, Banjac A, Schneider M, Beck H, Hatzopoulos AK, Just U, Sinowatz F et al (2004) Essential role for mitochondrial thioredoxin reductase in hematopoiesis, heart development, and heart function. Mol Cell Biol 24:9414\u20139423. https:\/\/doi.org\/10.1128\/MCB.24.21.9414-9423.2004","journal-title":"Mol Cell Biol"},{"key":"5288_CR49","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.tips.2017.06.001","volume":"38","author":"J Zhang","year":"2017","unstructured":"Zhang J, Li X, Han X, Liu R, Fang J (2017) Targeting the Thioredoxin System for Cancer Therapy. Trends Pharmacol Sci 38:794\u2013808. https:\/\/doi.org\/10.1016\/j.tips.2017.06.001","journal-title":"Trends Pharmacol Sci"},{"key":"5288_CR50","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1161\/01.RES.0000130525.37646.a7","volume":"94","author":"R Zhang","year":"2004","unstructured":"Zhang R, Al-Lamki R, Bai L, Streb JW, Miano JM, Bradley J, Min W (2004) Thioredoxin-2 inhibits mitochondria-located ASK1-mediated apoptosis in a JNK-independent manner. Circ Res 94:1483\u20131491. https:\/\/doi.org\/10.1161\/01.RES.0000130525.37646.a7","journal-title":"Circ Res"},{"issue":"3","key":"5288_CR51","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.tox.2013.07.005","volume":"311","author":"S Suzuki","year":"2013","unstructured":"Suzuki S, Pitchakarn P, Ogawa K, Naiki-Ito A, Chewonarin T, Punfa W, Asamoto M, Shirai T, Takahashi S (2013) Expression of glutathione peroxidase 2 is associated with not only early hepatocarcinogenesis but also late stage metastasis. Toxicology 311(3):115\u2013123. https:\/\/doi.org\/10.1016\/j.tox.2013.07.005","journal-title":"Toxicology"},{"key":"5288_CR52","doi-asserted-by":"publisher","first-page":"136","DOI":"10.24412\/2500-2295-2024-3-136-151","volume":"11","author":"EG Varlamova","year":"2024","unstructured":"Varlamova EG, Turovsky EA (2024) The Nature of Changes in mRNA Expression and the Relative Content of Selenoproteins in a Mouse Model with TAA-Induced Fibrosis and Hepatocellular Carcinoma (HCC) Opera Med. Physiol 11:136\u2013151. https:\/\/doi.org\/10.24412\/2500-2295-2024-3-136-151","journal-title":"Physiol"},{"key":"5288_CR53","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1186\/s12967-025-06468-5","volume":"23","author":"Y Tan","year":"2025","unstructured":"Tan Y, Yang L, Xu T, Wang Q, Huang M, Zhao Z, Chen X, Tang C, Tan W (2025) GPX2 inhibition enhances antitumor efficacy of lenvatinib via promoting immunogenic cell death in hepatocellular carcinoma. J Transl Med 23:456. https:\/\/doi.org\/10.1186\/s12967-025-06468-5","journal-title":"J Transl Med"},{"issue":"8","key":"5288_CR54","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1158\/2159-8290.CD-23-1220","volume":"14","author":"G Lei","year":"2024","unstructured":"Lei G, Mao C, Horbath AD, Yan Y, Cai S, Yao J, Jiang Y, Sun M, Liu X, Cheng J, Xu Z, Lee H, Li Q, Lu Z, Zhuang L, Chen MK, Alapati A, Yap TA, Hung MC, You MJ, Piwnica-Worms H, Gan B (2024) BRCA1-Mediated Dual Regulation of Ferroptosis Exposes a Vulnerability to GPX4 and PARP Co-Inhibition in BRCA1-Deficient Cancers. Cancer Discov 14(8):1476\u20131495. https:\/\/doi.org\/10.1158\/2159-8290.CD-23-1220","journal-title":"Cancer Discov"},{"issue":"7","key":"5288_CR55","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/s41419-022-05082-3","volume":"13","author":"W Zhang","year":"2022","unstructured":"Zhang W, Gong M, Zhang W, Mo J, Zhang S, Zhu Z, Wang X, Zhang B, Qian W, Wu Z, Ma Q, Wang Z (2022) Thiostrepton induces ferroptosis in pancreatic cancer cells through STAT3\/GPX4 signalling. Cell Death Dis 13(7):630. https:\/\/doi.org\/10.1038\/s41419-022-05082-3. Erratum in: Cell Death Dis. 2022;13(9):789. doi: 10.1038\/s41419-022-05236-3","journal-title":"Cell Death Dis"},{"issue":"10","key":"5288_CR56","doi-asserted-by":"publisher","first-page":"13515","DOI":"10.18632\/aging.202774","volume":"13","author":"C Yang","year":"2021","unstructured":"Yang C, Zhang Y, Lin S, Liu Y, Li W (2021) Suppressing the KIF20A\/NUAK1\/Nrf2\/GPX4 signaling pathway induces ferroptosis and enhances the sensitivity of colorectal cancer to oxaliplatin. Aging 13(10):13515\u201313534. https:\/\/doi.org\/10.18632\/aging.202774. Epub 2021 Mar 26. Erratum in: Aging (Albany NY). 2021;13(14):19077. doi: 10.18632\/aging.203382","journal-title":"Aging"},{"key":"5288_CR57","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.bbrc.2021.06.051","volume":"567","author":"J Ni","year":"2021","unstructured":"Ni J, Chen K, Zhang J, Zhang X (2021) Inhibition of GPX4 or mTOR overcomes resistance to Lapatinib via promoting ferroptosis in NSCLC cells. Biochem Biophys Res Commun 567:154\u2013160. https:\/\/doi.org\/10.1016\/j.bbrc.2021.06.051","journal-title":"Biochem Biophys Res Commun"},{"key":"5288_CR58","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nri2691","volume":"10","author":"JE Sims","year":"2010","unstructured":"Sims JE, Smith DE (2010) The IL-1 family: Regulators of immunity. Nat Rev Immunol 10:89\u2013102. https:\/\/doi.org\/10.1038\/nri2691","journal-title":"Nat Rev Immunol"},{"key":"5288_CR59","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1080\/14728222.2020.1744568","volume":"24","author":"C Larson","year":"2020","unstructured":"Larson C, Oronsky B, Carter CA, Oronsky A, Knox SJ, Sher D, Reid TR (2020) TGF-beta: A master immune regulator. Expert Opin Ther Targets 24:427\u2013438. https:\/\/doi.org\/10.1080\/14728222.2020.1744568","journal-title":"Expert Opin Ther Targets"},{"key":"5288_CR60","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1002\/jcb.25496","volume":"117","author":"V Syed","year":"2016","unstructured":"Syed V (2016) TGF-\u03b2 Signaling in Cancer. J Cell Biochem 117:1279\u20131287. https:\/\/doi.org\/10.1002\/jcb.25496","journal-title":"J Cell Biochem"},{"issue":"6","key":"5288_CR61","doi-asserted-by":"publisher","first-page":"786","DOI":"10.3390\/cancers11060786","volume":"11","author":"HP Ma","year":"2019","unstructured":"Ma HP, Chang HL, Bamodu OA, Yadav VK, Huang TY, Wu ATH, Yeh CT, Tsai SH, Lee WH (2019) Collagen 1A1 (COL1A1) Is a Reliable Biomarker and Putative Therapeutic Target for Hepatocellular Carcinogenesis and Metastasis. Cancers (Basel) 11(6):786. https:\/\/doi.org\/10.3390\/cancers11060786","journal-title":"Cancers (Basel)"},{"issue":"2","key":"5288_CR62","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s11010-024-05010-3","volume":"480","author":"Y Zhao","year":"2025","unstructured":"Zhao Y, Yu B, Wang Y, Tan S, Xu Q, Wang Z, Zhou K, Liu H, Ren Z, Jiang Z (2025) Ang-1 and VEGF: central regulators of angiogenesis. Mol Cell Biochem 480(2):621\u2013637. https:\/\/doi.org\/10.1007\/s11010-024-05010-3","journal-title":"Mol Cell Biochem"},{"issue":"2","key":"5288_CR63","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1002\/jcb.29380","volume":"121","author":"N Lin","year":"2020","unstructured":"Lin N, Meng L, Lin J, Chen S, Zhang P, Chen Q, Lin Y (2020) Activated hepatic stellate cells promote angiogenesis in hepatocellular carcinoma by secreting angiopoietin-1. J Cell Biochem 121(2):1441\u20131451. https:\/\/doi.org\/10.1002\/jcb.29380","journal-title":"J Cell Biochem"},{"issue":"2","key":"5288_CR64","doi-asserted-by":"publisher","first-page":"e0893","DOI":"10.1097\/HC9.0000000000000893","volume":"10","author":"Z Wang","year":"2026","unstructured":"Wang Z, Cao Z, Dong Y, Hong Y, Zuo L, Wang H (2026) Hepatocyte-hepatic stellate cell interactions in liver fibrosis: Mechanisms and therapeutic implications. Hepatol Commun 10(2):e0893. https:\/\/doi.org\/10.1097\/HC9.0000000000000893","journal-title":"Hepatol Commun"},{"issue":"23","key":"5288_CR65","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.3390\/cells12232723","volume":"12","author":"EG Varlamova","year":"2023","unstructured":"Varlamova EG, Goltyaev MV, Rogachev VV, Gudkov SV, Karaduleva EV, Turovsky EA (2023) Antifibrotic Effect of Selenium-Containing Nanoparticles on a Model of TAA-Induced Liver Fibrosis. Cells 12(23):2723. https:\/\/doi.org\/10.3390\/cells12232723","journal-title":"Cells"},{"issue":"1","key":"5288_CR66","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3892\/ol.2016.4622","volume":"12","author":"Y Yang","year":"2016","unstructured":"Yang Y, Wang JB, Li YM, Zhao YU, Wang R, Wu Q, Zheng RS, Ou YR (2016) Role of IL-33 expression in oncogenesis and development of human hepatocellular carcinoma. Oncol Lett 12(1):429\u2013436. https:\/\/doi.org\/10.3892\/ol.2016.4622","journal-title":"Oncol Lett"},{"issue":"2","key":"5288_CR67","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.cgh.2022.01.047","volume":"21","author":"N Tayob","year":"2023","unstructured":"Tayob N, Kanwal F, Alsarraj A, Hernaez R, El-Serag HB (2023) The Performance of AFP, AFP-3, DCP as Biomarkers for Detection of Hepatocellular Carcinoma (HCC): A Phase 3 Biomarker Study in the United States. Clin Gastroenterol Hepatol 21(2):415\u2013423e4. https:\/\/doi.org\/10.1016\/j.cgh.2022.01.047","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"5288_CR68","doi-asserted-by":"publisher","first-page":"559","DOI":"10.22088\/cjim.15.4.559","volume":"15","author":"M Lubis","year":"2024","unstructured":"Lubis M, Darmadi D, Samuel Surja S, Pakpahan C (2024) Diagnostic value of Midkine and AFP in the detection of hepatocellular carcinoma: A systematic review and meta-analysis. Casp J Intern Med 15(4):559\u2013569. https:\/\/doi.org\/10.22088\/cjim.15.4.559","journal-title":"Casp J Intern Med"},{"issue":"3","key":"5288_CR69","doi-asserted-by":"publisher","first-page":"e215","DOI":"10.5301\/jbm.5000064","volume":"29","author":"BI Carr","year":"2014","unstructured":"Carr BI, Guerra V, Giannini EG, Farinati F, Ciccarese F, Rapaccini GL, Di Marco M, Benvegn\u00f9 L, Zoli M, Borzio F, Caturelli E, Chiaramonte M, Trevisani F, Italian Liver Cancer Group (2014) Significance of platelet and AFP levels and liver function parameters for HCC size and survival. Int J Biol Markers 29(3):e215\u2013e223. https:\/\/doi.org\/10.5301\/jbm.5000064","journal-title":"Int J Biol Markers"},{"issue":"5","key":"5288_CR70","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.hbpd.2020.02.009","volume":"19","author":"WL Sai","year":"2020","unstructured":"Sai WL, Yao M, Shen SJ, Zheng WJ, Sun JY, Wu MN, Wang L, Yao DF (2020) Dynamic expression of hepatic GP73 mRNA and protein and circulating GP73 during hepatocytes malignant transformation. Hepatobiliary Pancreat Dis Int 19(5):449\u2013454. https:\/\/doi.org\/10.1016\/j.hbpd.2020.02.009","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"10","key":"5288_CR71","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41389-021-00358-3","volume":"10","author":"Y Liu","year":"2021","unstructured":"Liu Y, Wang J, Yang R, Cheng Y, Zhou Y, Li H, Jiang W, Zhang X (2021) GP73-mediated secretion of AFP and GP73 promotes proliferation and metastasis of hepatocellular carcinoma cells. Oncogenesis 10(10):69. https:\/\/doi.org\/10.1038\/s41389-021-00358-3","journal-title":"Oncogenesis"},{"key":"5288_CR72","doi-asserted-by":"publisher","first-page":"1571761","DOI":"10.3389\/fmed.2025.1571761","volume":"12","author":"Q Wang","year":"2025","unstructured":"Wang Q, Cui H, Zhu Y, Zhu Y, He C (2025) Serum Golgi protein 73 (GP73) is a diagnostic and prognostic marker of hepatocellular carcinoma. Front Med (Lausanne) 12:1571761. https:\/\/doi.org\/10.3389\/fmed.2025.1571761","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"5288_CR73","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/bjc.2011.269","volume":"105","author":"A Ravindranath","year":"2011","unstructured":"Ravindranath A, Yuen HF, Chan KK, Grills C, Fennell DA, Lappin TR, El-Tanani M (2011) Wnt-\u03b2-catenin-Tcf-4 signalling-modulated invasiveness is dependent on osteopontin expression in breast cancer. Br J Cancer 105(4):542\u2013551. https:\/\/doi.org\/10.1038\/bjc.2011.269","journal-title":"Br J Cancer"},{"issue":"7","key":"5288_CR74","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.3390\/biomedicines12071527","volume":"12","author":"VK Panda","year":"2024","unstructured":"Panda VK, Mishra B, Nath AN, Butti R, Yadav AS, Malhotra D, Khanra S, Mahapatra S, Mishra P, Swain B, Majhi S, Kumari K, Radharani NNV, Kundu GC (2024) Osteopontin: A Key Multifaceted Regulator in Tumor Progression and Immunomodulation. Biomedicines 12(7):1527. https:\/\/doi.org\/10.3390\/biomedicines12071527","journal-title":"Biomedicines"},{"issue":"2","key":"5288_CR75","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nrm3270","volume":"13","author":"C Hetz","year":"2012","unstructured":"Hetz C (2012) The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat Rev Mol Cell Biol 13(2):89\u2013102. https:\/\/doi.org\/10.1038\/nrm3270","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5288_CR76","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1146\/annurev-pathol-012513-104649","volume":"10","author":"SA Oakes","year":"2015","unstructured":"Oakes SA, Papa FR (2015) The role of endoplasmic reticulum stress in human pathology. Annu Rev Pathol 10:173\u2013194. https:\/\/doi.org\/10.1146\/annurev-pathol-012513-104649","journal-title":"Annu Rev Pathol"},{"issue":"6","key":"5288_CR77","doi-asserted-by":"publisher","first-page":"4691","DOI":"10.1007\/s11033-020-05518-z","volume":"47","author":"A Nazmeen","year":"2020","unstructured":"Nazmeen A, Chen G, Maiti S (2020) Dependence between estrogen sulfotransferase (SULT1E1) and nuclear transcription factor Nrf-2 regulations via oxidative stress in breast cancer. Mol Biol Rep 47(6):4691\u20134698. https:\/\/doi.org\/10.1007\/s11033-020-05518-z","journal-title":"Mol Biol Rep"},{"issue":"1","key":"5288_CR78","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1134\/S160767292001007X","volume":"490","author":"MV Goltyaev","year":"2020","unstructured":"Goltyaev MV, Varlamova EG, Novoselov SV, Fesenko EE (2020) Activation of Signal Pathways of Apoptosis under Conditions of Prolonged ER-Stress Caused by Exposure of Mouse Testicular Teratoma Cells to Selenium-Containing Compounds. Dokl Biochem Biophys 490(1):9\u201311. https:\/\/doi.org\/10.1134\/S160767292001007X","journal-title":"Dokl Biochem Biophys"},{"key":"5288_CR79","doi-asserted-by":"publisher","first-page":"144884","DOI":"10.1016\/j.gene.2020","volume":"755","author":"MV Goltyaev","year":"2020","unstructured":"Goltyaev MV, Mal\u2019tseva VN, Varlamova EG (2020) Expression of ER-resident selenoproteins and activation of cancer cells apoptosis mechanisms under ER-stress conditions caused by methylseleninic acid. Gene 755:144884. https:\/\/doi.org\/10.1016\/j.gene.2020","journal-title":"Gene"},{"key":"5288_CR80","doi-asserted-by":"publisher","unstructured":"Mal\u2019tseva VN, Goltyaev MV, Novoselov SV, Varlamova EG (2022) Effects of sodium selenite and dithiothreitol on expression of endoplasmic reticulum selenoproteins and apoptosis markers in msf7 breast adenocarcinoma cells. Mol Biol (Mosk) Russian. 56(1):135\u2013146 https:\/\/doi.org\/10.31857\/S0026898422010062","DOI":"10.31857\/S0026898422010062"},{"issue":"1\u20133","key":"5288_CR81","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1163\/156856005774423863","volume":"13","author":"A Yanaka","year":"2005","unstructured":"Yanaka A, Zhang S, Tauchi M, Suzuki H, Shibahara T, Matsui H, Nakahara A, Tanaka N, Yamamoto M (2005) Role of the nrf-2 gene in protection and repair of gastric mucosa against oxidative stress. Inflammopharmacology 13(1\u20133):83\u201390. https:\/\/doi.org\/10.1163\/156856005774423863","journal-title":"Inflammopharmacology"},{"key":"5288_CR82","doi-asserted-by":"publisher","unstructured":"Solano-Urrusquieta A, Morales-Gonz\u00e1lez JA, Castro-Narro GE, Cerda-Reyes E, Flores-Rangel PD, Fierros-Oceguera R (2020) NRF-2 and nonalcoholic fatty liver disease. Ann Hepatol 19(5):458\u2013465. https:\/\/doi.org\/10.1016\/j.aohep.2019.11.010","DOI":"10.1016\/j.aohep.2019.11.010"},{"issue":"1","key":"5288_CR83","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","volume":"7","author":"J Liu","year":"2022","unstructured":"Liu J, Xiao Q, Xiao J, Niu C, Li Y, Zhang X, Zhou Z, Shu G, Yin G (2022) Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduct Target Ther 7(1):3. https:\/\/doi.org\/10.1038\/s41392-021-00762-6","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"5288_CR84","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41392-021-00701-5","volume":"6","author":"F Yu","year":"2021","unstructured":"Yu F, Yu C, Li F, Zuo Y, Wang Y, Yao L, Wu C, Wang C, Ye L (2021) Wnt\/\u03b2-catenin signaling in cancers and targeted therapies. Signal Transduct Target Ther 6(1):307. https:\/\/doi.org\/10.1038\/s41392-021-00701-5","journal-title":"Signal Transduct Target Ther"},{"key":"5288_CR85","doi-asserted-by":"publisher","first-page":"110851","DOI":"10.1016\/j.biopha.2020.110851","volume":"132","author":"S He","year":"2020","unstructured":"He S, Tang S (2020) WNT\/\u03b2-catenin signaling in the development of liver cancers. Biomed Pharmacother 132:110851. https:\/\/doi.org\/10.1016\/j.biopha.2020.110851","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"5288_CR86","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.3892\/etm.2020.8454","volume":"19","author":"YJ Guo","year":"2020","unstructured":"Guo YJ, Pan WW, Liu SB, Shen ZF, Xu Y, Hu LL (2020) ERK\/MAPK signalling pathway and tumorigenesis. Exp Ther Med 19(3):1997\u20132007. https:\/\/doi.org\/10.3892\/etm.2020.8454","journal-title":"Exp Ther Med"},{"key":"5288_CR87","doi-asserted-by":"publisher","first-page":"152364","DOI":"10.1016\/j.bbrc.2025.152364","volume":"778","author":"EG Varlamova","year":"2025","unstructured":"Varlamova EG, Burmistrov DE, Gudkov SV, Rogachev VV, Turovsky EA (2025) Comparative analysis of anticancer properties of So and selenium nanoparticles in a thioacetamide-induced HCC model. Biochem Biophys Res Commun 778:152364. https:\/\/doi.org\/10.1016\/j.bbrc.2025.152364","journal-title":"Biochem Biophys Res Commun"},{"key":"5288_CR88","doi-asserted-by":"publisher","first-page":"122351","DOI":"10.1016\/j.lfs.2023.122351","volume":"337","author":"S Manoharan","year":"2024","unstructured":"Manoharan S, Saha S, Murugesan K, Santhakumar A, Perumal E (2024) Natural bioactive compounds and STAT3 against hepatocellular carcinoma: An update. Life Sci 337:122351. https:\/\/doi.org\/10.1016\/j.lfs.2023.122351","journal-title":"Life Sci"},{"issue":"1","key":"5288_CR89","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/cr.2010.183","volume":"21","author":"G He","year":"2011","unstructured":"He G, Karin M (2011) NF-\u03baB and STAT3 - key players in liver inflammation and cancer. Cell Res 21(1):159\u2013168. https:\/\/doi.org\/10.1038\/cr.2010.183","journal-title":"Cell Res"},{"issue":"5","key":"5288_CR90","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.cell.2014.04.019","volume":"157","author":"JA Rickard","year":"2014","unstructured":"Rickard JA, O\u2019Donnell JA, Evans JM, Lalaoui N, Poh AR, Rogers T, Vince JE, Lawlor KE, Ninnis RL, Anderton H, Hall C, Spall SK, Phesse TJ, Abud HE, Cengia LH, Corbin J, Mifsud S, Di Rago L, Metcalf D, Ernst M, Dewson G, Roberts AW, Alexander WS, Murphy JM, Ekert PG, Masters SL, Vaux DL, Croker BA, Gerlic M, Silke J (2014) RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis. Cell 157(5):1175\u20131188. https:\/\/doi.org\/10.1016\/j.cell.2014.04.019","journal-title":"Cell"},{"key":"5288_CR91","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.semcancer.2021.06.019","volume":"85","author":"L Yu","year":"2022","unstructured":"Yu L, Wei J, Liu P (2022) Attacking the PI3K\/Akt\/mTOR signaling pathway for targeted therapeutic treatment in human cancer. Semin Cancer Biol 85:69\u201394. https:\/\/doi.org\/10.1016\/j.semcancer.2021.06.019","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"5288_CR92","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.3390\/ijms24032652","volume":"24","author":"LY Tian","year":"2023","unstructured":"Tian LY, Smit DJ, J\u00fccker M (2023) The Role of PI3K\/AKT\/mTOR Signaling in Hepatocellular Carcinoma Metabolism. Int J Mol Sci 24(3):2652. https:\/\/doi.org\/10.3390\/ijms24032652","journal-title":"Int J Mol Sci"}],"container-title":["Biological Trace Element Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12011-026-05288-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12011-026-05288-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12011-026-05288-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:40:09Z","timestamp":1793086809000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12011-026-05288-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":92,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["5288"],"URL":"https:\/\/doi.org\/10.1007\/s12011-026-05288-y","relation":{},"ISSN":["1559-0720"],"issn-type":[{"value":"1559-0720","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]},"assertion":[{"value":"12 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declaration"}}]}}